Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors

Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors

Steven H Ferris,1 Martin Farlow21Alzheimer's Disease Center, Comprehensive Center on Brain Aging, New York University Langone Medical Center, New York, NY, 2Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USAAbstract: Alzheimer's disease is character...

Full description

Bibliographic Details
Main Authors:	Ferris SH, Farlow M
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-08-01
Series:	Clinical Interventions in Aging
Subjects:	Alzheimer's disease donepezil cognition language communication clinical trials
Online Access:	https://www.dovepress.com/language-impairment-in-alzheimer39s-disease-and-benefits-of-acetylchol-peer-reviewed-article-CIA

Similar Items

Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer’s Disease: Are Irreversible Inhibitors the Future?
by: Donald E. Moss
Published: (2020-05-01)

A double-blind placebo-controlled cross-over clinical trial of DONepezil In Posterior cortical atrophy due to underlying Alzheimer's Disease: DONIPAD study
by: Basil H. Ridha, et al.
Published: (2018-05-01)

Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease
by: Tariot Pierre, et al.
Published: (2012-06-01)

Clinical Assessment of Alzheimer’s Disease and Response to Donepezil Treatment
by: Serge Gauthier
Published: (2020-12-01)

Synthesis of New Indole Derivatives Structurally Related to Donepezil and Their Biological Evaluation as Acetylcholinesterase Inhibitors
by: Samar I. Faggal, et al.
Published: (2012-04-01)

Targeted Screening for Alzheimer's Disease Clinical Trials Using Data-Driven Disease Progression Models
by: Alexander, D.C, et al.
Published: (2022)

Development of donepezil-induced hypokalemia following treatment of cognitive impairment
by: Dongryul Kim, et al.
Published: (2021-01-01)

The effect of cholinesterase inhibitors on sleep in the patients with Alzheimer’s disease: an observational prospective study
by: Osman Korucu, et al.
Published: (2018-01-01)

Donepezil prevents RANK-induced bone loss via inhibition of osteoclast differentiation by downregulating acetylcholinesterase
by: Tsuyoshi Sato, et al.
Published: (2015-09-01)

Delirium associated with donepezil in a patient with Alzheimer's disease: a case report.
by: Kamyar Mollazadeh-Moghaddam, et al.
Published: (2013-03-01)

Delirium Associated with Donepezil in a Patient with Alzheimer’s Disease: a Case Report
by: Kamyar Mollazadeh-Moghaddam, et al.
Published: (2013-03-01)

Efficacy of bacopa monnieri (Brahmi) and Donepezil in Alzheimer's Disease and mild cognitive impairment: A randomized double-blind parallel Phase 2b study
by: Sudesh Prabhakar, et al.
Published: (2020-01-01)

Acetylcholinesterase Inhibitor Improves Learning and Memory Impairment Induced by Toxoplasma gondii Infection
by: Hossein MAHMOUDVAND, et al.
Published: (2016-12-01)

Effects of Donepezil Hydrochloride on Neuronal Response of Pyramidal Neuron of the CA1 Hippocampus in Rat Model of Alzheimer\'s Disease
by: Azade Eskandary, et al.
Published: (2019-03-01)

Different Doses of Pharmacological Treatments for Mild to Moderate Alzheimer’s Disease: A Bayesian Network Meta-Analysis
by: Tingting Zhang, et al.
Published: (2020-05-01)

Multi-target directed donepezil-like ligands for Alzheimer's disease
by: Mercedes eUnzeta, et al.
Published: (2016-05-01)

The Effects of Donepezil on 15-Item Geriatric Depression Scale Structure in Patients with Alzheimer Disease
by: Youngsoon Yang, et al.
Published: (2016-09-01)

Donepezil Treatment for Alzheimer’s Disease in Chronic Dialysis Patients
by: Konstantina G. Yiannopoulou, et al.
Published: (2019-09-01)

Effect of co-administration of donepezil and folic acid on spatial memory impairment in adult male rat model of Alzheimer's disease
by: Azade Eskandary, et al.
Published: (2018-12-01)

Musical hallucinations treated with acetylcholinesterase inhibitors
by: Jan Dirk eBlom, et al.
Published: (2015-04-01)

Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
by: Zhang N, et al.
Published: (2018-10-01)

Evaluation of the Adverse Effects of Chronic Exposure to Donepezil (An Acetylcholinesterase Inhibitor) in Adult Zebrafish by Behavioral and Biochemical Assessments
by: Gilbert Audira, et al.
Published: (2020-09-01)

Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease: a randomized, double-blind and controlled trial
by: Elmira Akbari, et al.
Published: (2016-11-01)

Effect of donepezil hydrochloride on reference and working memory impairment after bilateral electrical lesion of nucleus basalis magnocellularis in rats model of Alzheimer disease
by: Azade Eskandary, et al.
Published: (2018-03-01)

Cholinesterase inhibitors for Parkinson’s disease-related visual hallucinations unresponsive to atypical antipsychotics
by: Tomasz Sobow
Published: (2007-03-01)

The effect of electroacupuncture combined with donepezil on cognitive function in Alzheimer’s disease patients: study protocol for a randomized controlled trial
by: Weina Peng, et al.
Published: (2017-07-01)

Characterization and evaluation of porous hydroxyapatite synthesized by oil-in-water method as carrier of donepezil for the preventive of Alzheimer’s disease by controlled release
by: Chih-Hsiang Fang, et al.
Published: (2020-10-01)

Alzheimer’s disease: clinical management errors
by: V. A. Parfenov
Published: (2020-12-01)

Differential Effects of Acetylcholinesterase Inhibitors on Clinical Responses and Cerebral Blood Flow Changes in Patients with Alzheimer's Disease: A 12-Month, Randomized, and Open-Label Trial
by: Soichiro Shimizu, et al.
Published: (2015-04-01)

Postoperative Administration of the Acetylcholinesterase Inhibitor, Donepezil, Interferes with Bone Healing and Implant Osseointegration in A Rat Model
by: Faez Saleh Al-Hamed, et al.
Published: (2020-09-01)

Efficiency of donepezil in elderly patients undergoing orthopaedic surgery due to underlying post-operative cognitive dysfunction: study protocol for a multicentre randomised controlled trial
by: Huichen Zhu, et al.
Published: (2021-10-01)

Language and cognition in Alzheimer's disease / Linguagem e cognição na doença de Alzheimer
by: Letícia Lessa Mansur, et al.
Published: (2005-01-01)

Gintonin facilitates brain delivery of donepezil, a therapeutic drug for Alzheimer disease, through lysophosphatidic acid 1/3 and vascular endothelial growth factor receptors
by: Sun-Hye Choi, et al.
Published: (2021-03-01)

Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease
by: Dan-Dan Li, et al.
Published: (2019-05-01)

Effekten av donepezil vid mild-måttlig Alzheimers sjukdom mätt med Mini mental state exam
by: Nilsson, Molly
Published: (2016)

Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease
by: Geifman, Nophar, et al.
Published: (2017)

Alzheimer disease and acetylcholinesterase inhibitors
by: Zahia Kabouche
Published: (2016-12-01)

Pharmaco-fUS for Characterizing Drugs for Alzheimer’s Disease – The Case of THN201, a Drug Combination of Donepezil Plus Mefloquine
by: Benjamin Vidal, et al.
Published: (2020-08-01)

Influence of Acetylcholinesterase Inhibitors Used in Alzheimer’s Disease Treatment on the Activity of Antioxidant Enzymes and the Concentration of Glutathione in <i>THP-1</i> Macrophages under Fluoride-Induced Oxidative Stress
by: Marta Goschorska, et al.
Published: (2018-12-01)

Effect of Donepezil and Hyoscyamoside on Improving Spatial Memory in Rats With Alzheimer\'s Disease
by: Fatemeh Heidari Soureshjani, et al.
Published: (2020-09-01)